- Report
- March 2025
- 195 Pages
Global
From €5247EUR$5,950USD£4,543GBP
- Report
- August 2025
- 190 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- August 2025
- 181 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- August 2025
- 198 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- August 2025
- 189 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- April 2025
- 175 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- April 2025
- 200 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- March 2025
- 250 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- January 2025
- 175 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- March 2025
- 150 Pages
Global
From €3395EUR$3,850USD£2,939GBP
€4277EUR$4,850USD£3,703GBP
- Report
- January 2025
- 175 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- September 2025
- 381 Pages
Global
From €5159EUR$5,850USD£4,466GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1764EUR$2,000USD£1,527GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1323EUR$1,500USD£1,145GBP
- Report
- January 2025
- 143 Pages
Global
From €2645EUR$2,999USD£2,290GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2460EUR$2,789USD£2,129GBP
- Report
- August 2024
- 150 Pages
Global
From €3395EUR$3,850USD£2,939GBP
€4277EUR$4,850USD£3,703GBP
- Report
- January 2024
- 150 Pages
Global
From €3395EUR$3,850USD£2,939GBP
€4277EUR$4,850USD£3,703GBP
- Report
- August 2022
- 118 Pages
Global
From €3969EUR$4,500USD£3,436GBP
- Report
- April 2023
- 180 Pages
Global
From €2646EUR$3,000USD£2,290GBP

Colony Stimulating Factor (CSF) is a type of drug used to treat immune disorders. It is a type of cytokine, a protein that helps regulate the immune system. CSF drugs are used to treat a variety of conditions, including neutropenia, anemia, and certain types of cancer. They can also be used to reduce the risk of infection in patients with weakened immune systems. CSF drugs work by stimulating the production of white blood cells, which help fight infection.
CSF drugs are typically administered intravenously or subcutaneously. Common side effects include fever, chills, nausea, and headache. In some cases, CSF drugs can cause allergic reactions or anaphylaxis.
The CSF market is a growing segment of the immune disorders drugs market. It is expected to continue to grow as more treatments become available and as the demand for immune-related treatments increases.
Some companies in the CSF market include Amgen, Biogen, Celgene, and Novartis. Show Less Read more